Centro Medicina Primaria Vega Alta | |
Carr 2 Km 31.9 Bo. Bajura Vega Alta PR 00692 | |
(787) 883-0124 | |
(787) 883-7645 |
Full Name | Centro Medicina Primaria Vega Alta |
---|---|
Speciality | General Practice |
Location | Carr 2 Km 31.9, Vega Alta, Puerto Rico |
Authorized Official Name and Position | Mildalias Dominguez Pascual (PRESIDENT) |
Authorized Official Contact | 7878830124 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Centro Medicina Primaria Vega Alta P.o. Box 4317 Vega Baja PR 00694-4317 Ph: (787) 883-0124 | Centro Medicina Primaria Vega Alta Carr 2 Km 31.9 Bo. Bajura Vega Alta PR 00692 Ph: (787) 883-0124 |
NPI Number | 1184708448 |
---|---|
Provider Enumeration Date | 10/24/2006 |
Last Update Date | 02/25/2008 |
Medicare PECOS PAC ID | 2365405586 |
---|---|
Medicare Enrollment ID | O20041109000668 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1184708448 | NPI | - | NPPES |
19197 | Other | PR | TRIPLE S |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | (* (Not Available)) | Primary |
Provider Name | Reinaldo Rios Rodriguez |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1063631901 PECOS PAC ID: 7012982820 Enrollment ID: I20040826000453 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Fernando A Garcia Cruz |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1316041809 PECOS PAC ID: 2163485392 Enrollment ID: I20100423000305 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Kareen T Tirado |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1811933633 PECOS PAC ID: 4981870433 Enrollment ID: I20120104000497 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Elvira Perez Perez |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1902139587 PECOS PAC ID: 7618136722 Enrollment ID: I20120309000076 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Vivian Lopez Lorenzo |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1235229048 PECOS PAC ID: 1254591480 Enrollment ID: I20120327000269 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Jose Luis Alvarez |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1568846590 PECOS PAC ID: 5799094033 Enrollment ID: I20151027002365 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Glorymar Ortiz Cordero |
---|---|
Provider Type | Practitioner - Pediatric Medicine |
Provider Identifiers | NPI Number: 1295143758 PECOS PAC ID: 6901168871 Enrollment ID: I20180313002367 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Gerardo Jose Lopez-cepero |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1366914350 PECOS PAC ID: 0446670673 Enrollment ID: I20201008003319 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Joseph Anthony Mendez Gomez |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1316591548 PECOS PAC ID: 8820418981 Enrollment ID: I20201012002527 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Lorenzo Rivera |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1730814021 PECOS PAC ID: 4880063080 Enrollment ID: I20221209002683 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Provider Name | Keysha Karelis Reyes Olivo |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1386392793 PECOS PAC ID: 4284004169 Enrollment ID: I20230111000291 |
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
News Archive
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.
A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
› Verified 9 days ago
Clinica Georgetti Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 58 Calle Georgetti, Vega Alta, PR 00692 Phone: 787-883-1379 Fax: 787-883-1360 | |
Cf Medical Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Estancias De Cerro Gordo, 96 Plaza Carmen, Vega Alta, PR 00692 Phone: 787-308-3566 Fax: 787-915-7386 | |
Gemelle Medical Services Psc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Carr. #2 Km 30 Sector Espinosa 17-d, Vega Alta, PR 00692 Phone: 787-915-6224 Fax: 787-915-6223 | |
Salud Directa De Puerto Rico Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Calle Luis Munoz Rivera #3, Vega Alta, PR 00692 Phone: 787-883-0124 Fax: 787-883-0222 | |
Dr Gustavo Cedeno Quintero Psc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 58 Calle Eduardo Georgetti, Vega Alta, PR 00692 Phone: 787-484-5103 | |
Angelorum, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Carr 693 Km 13.8, Suite 171 Bo Brenas, Vega Alta, PR 00692 Phone: 787-270-3330 Fax: 787-915-7594 |